title: The concentration of antibiotic in fresh-frozen bone graft.
abstract: We investigated the antibiotic concentration in fresh-frozen femoral head allografts harvested from two groups of living donors. Ten samples were collected from patients with osteoarthritis of the hip and ten from those with a fracture of the neck of the femur scheduled for primary arthroplasty. Cefazolin (1 g) was administered as a pre-operative prophylactic antibiotic. After storage at -80 degrees C for two weeks the pattern of release of cefazolin from morsellised femoral heads was evaluated by an in vitro broth elution assay using high-performance liquid chromatography. The bioactivity of the bone was further determined with an agar disc diffusion and standardised tube dilution bioassay. The results indicated that the fresh-frozen femoral heads contained cefazolin. The morsellised bone released cefazolin for up to four days. The concentration of cefazolin was significantly higher in the heads from patients with osteoarthritis of the hip than in those with a fracture.Also, in bioassays the bone showed inhibitory effects against bacteria.We concluded that allografts of morsellised bone from the femoral head harvested from patients undergoing arthroplasty of the hip contained cefazolin, which had been administered pre-operatively and they exhibited inhibitory effects against bacteria in vitro.
authors.affiliation: Chang Gung University, Taoyuan, Taiwan.
authors.forename: Y
authors.initials: Y
authors.lastname: Chang
authors.forename: H-N
authors.initials: HN
authors.lastname: Shih
authors.forename: D W
authors.initials: DW
authors.lastname: Chen
authors.forename: M S
authors.initials: MS
authors.lastname: Lee
authors.forename: S W
authors.initials: SW
authors.lastname: Ueng
authors.forename: P-H
authors.initials: PH
authors.lastname: Hsieh
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D000900:Anti-Bacterial Agents / Q000008:administration & dosage / Q000493:pharmacokinetics* / Q000494:pharmacology; D019644:Arthroplasty, Replacement, Hip; D002437:Cefazolin / Q000008:administration & dosage / Q000493:pharmacokinetics* / Q000494:pharmacology; D002851:Chromatography, High Pressure Liquid; D015925:Cryopreservation / Q000379:methods; D052978:Disk Diffusion Antimicrobial Tests / Q000379:methods; D005260:Female; D005265:Femoral Neck Fractures / Q000378:metabolism / Q000601:surgery; D005270:Femur Head / Q000378:metabolism* / Q000637:transplantation; D006801:Humans; D007275:Injections, Intravenous; D019520:Living Donors; D008297:Male; D008875:Middle Aged; D009926:Organ Preservation / Q000379:methods; D015207:Osteoarthritis, Hip / Q000378:metabolism / Q000601:surgery; D013211:Staphylococcus aureus / Q000187:drug effects; D013997:Time Factors; D020858:Tissue and Organ Harvesting; D014184:Transplantation, Homologous
chemical_list: D000900:Anti-Bacterial Agents; D002437:Cefazolin